Have you checked that my treatment is safe? DrugLog® provides a fast and user-friendly way for the pharmacy or hospital personnel to check that the intended IV treatment has the correct content and concentration. pharmacolog.se CHECK T HAT T HE T RE AT M E NT I S S AF E ABOUT US Pharmacolog AB is a medical device company based in Uppsala, Sweden. The company specializes in providing quality assurance solutions for safe administration of medical IV drugs. The long term vision for the company is to play an active role in developing adaptive treatment methods with IV drugs. Pharmacolog AB has developed a system that can prevent errors in drug administration. The company’s lead product, DrugLog®, focuses on the quality assurance in IV drug administration at the hospital pharmacy and clinical wards. THE SOLUTION DrugLog® is a combination of hardware and software that through a patented process can identify the drug being prepared and verify its concentration, prior to patient infusion. The method reduces the risk of errors in drug management and the associated consequences for patients and clinical personnel (liability). PREPARATION AND ADMINISTRATION OF DRUGS In most hospitals the reconstitution and preparation of complex drugs takes place in centralized units typically in a controlled environment with experienced staff. The preparation and administration of toxic drugs is sometimes complex and the risk of errors and system failures could result in harmful outcome for the patient. Therefore extra measures need to be taken to ensure patient safety and prevent medication errors. Quality assurance systems are essential in order to dispense safe and accurate medications. These systems are becoming more widely used, however DrugLog provides real qualitative and quantitative testing that provides additional security for patients and staff. THE DrugLog® TECHNOLOGY The core technology is based on absorption spectroscopy in the ultraviolet (UV) and visual spectral range. In order to identify the drug to be tested a broad band spectral analysis of the liquid sample is made and matched against stored reference spectral data for calibrated drugs. Each drug to be compounded at a drug preparation unit shall be calibrated in advance and stored in the system as a reference. In this way generic drugs differences in spectral response can be identified which is used to automatically identify an accurate product. DrugLog® has been tested and verified at hospital pharmacies in Sweden and Switzerland preparing cytostatic drugs as well as insulin, morphine and different antibiotics for treatment of cancer patients. SYSTEM INTEGRATION DrugLog® has a built-in computer that can be connected to local networks for integrating with existing patient, treatment, drug prescription records, and other related databases. The system is connected to internet via the local Wi-Fi network which enables remote service and support by Pharmacolog. The CEO of the company is Hans Dahlin, with a clinical and company leadership background in cancer care for more than 30 years. WHY PHARMACOLOG ”After 30 years in clinical work, research and companies focused on developing methods and solutions for better cancer care with radiotherapy, I realized in early 2000 that to achieve an overall better and more individualized treatment of cancer, other disciplines like chemotherapy had to be improved. Research showed considerable lack of accuracy and safety when treating patients with intravenous drugs, which very often also resulted in serious mistreatments, patient suffering and substantial costs for the society. Several technical innovations and clinical tests made it possible to establish the company Pharmacolog in 2007. The business idea for Pharmacolog was to develop a product based on spectroscopic technology for securing treatment with intravenous drugs so that the right drug, with the right concentration, is given at the right time and to the right patient. Now Pharmacolog can present a stable and userfriendly first product to the market. DrugLog can play an important role in preventing mistreatments and patient sufferings, which directly improve the life for patients, and will decrease healthcare costs. Pharmacolog’s long-term goal is to continue the mission to develop tools and methods together with research centers, other MedTech and Drug companies, to make planning of IV drugs and follow up for individualized treatment possible.” Hans Dahlin, CEO Pharmacolog AB PHARMACOLOG AB Ekeby Bruk A14 • SE-752 75 Uppsala • Sweden • pharmacolog.se